Women's Fem Dophilus By Jarrow Formulas Overview & Drug Interactions
Check For Interactions With Women's Fem Dophilus
Supplement: Women's Fem Dophilus by Jarrow Formulas
Women's Fem Dophilus Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Total Probiotic Blend
| Ingredient Group | Blend (non-nutrient/non-botanical) |
|---|---|
| Category | blend |
-
Lactobacillus rhamnosus, GR-1
Ingredient Group Lactobacillus rhamnosus Category bacteria
Lactobacillus reuteri, RC-14
Ingredient Group Lactobacillus reuteri Category bacteria
Drugs that interact with Women's Fem Dophilus by Jarrow Formulas
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with Women's Fem Dophilus. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| Servings per container | 60 |
| UPC/BARCODE | 790011030300 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Total Probiotic Blend |
5000000000 Viable Cell(s)
|
Blend (non-nutrient/non-botanical) |
--
|
| Lactobacillus rhamnosus, GR-1 |
0 NP
|
Lactobacillus rhamnosus |
|
| Lactobacillus reuteri, RC-14 |
0 NP
|
Lactobacillus reuteri |
|
| Other Ingredients: |
Anhydrous Dextrose
Potato Starch
Cellulose
Magnesium Stearate
Capsule
Forms
|
|---|
Label Statments:
| Formula |
- Fem-Dophilus(R) contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1(R) and Lactobacillus reuteri, RC-14(R), discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech.
- PATENTED STRAINS LACTOBACILLUS RHAMNOSUS GR-1(R) and LACTOBACILLUS REUTERI RC-14(R)
- Contains: Dairy (casein, in trace amounts).
|
|---|---|
| Brand IP Statement(s) |
- Over 25 years of research supports the oral use of GR-1(R) and RC-14(R) to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus(R) from stomach acid and enhances probiotic bacterial survival to the lower intestine.
- Jarrow Formulas(R) puts the “PRO” in probiotics(R)
- (C) 2014 Jarrow FORMULAS(R)
- GR-1(R)/RC-14(R) and VAGINAL FLORA
In one of the randomized clinical trials, 75% of women in the GR-1(R)/RC-14(R) probiotic + antibiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (antibiotic only) group experienced similar improvement.
GR-1/RC-14(R) 75%
Control Group 34%
- RC-14(R) and GR-1(R) are Trademarks of Chr. Hansen A/S.
|
| General Statements |
- 04214FEM60 PROD # 103030
- 25+ YEARS OF RESEARCH/CLINICAL STUDIES
- Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.
- VAGINAL/URINARY TRACT HEALTH
- Made in Denmark by Chr. Hansen A/S
- Martinez, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1(R), and Lactobacillus reuteri RC-14(R) : a randomized, double-blind, placebo-controlled trial. Can J Microbiol 2009;55:133-138
{chart} 25+ YEARS OF GR-1(R)/ RC-14(R) RESEARCH / CLINICAL STUDIES
Fem-Dophilus(R) Introduced (2006)
1988 1994 2000 2006 2012 2014
1988-First Research on GR-1(R)/RC-14(R) Strains Begin -27 Clinical Studies Published Between 2001 and 2014
|
| Suggested/Recommended/Usage/Directions |
- 5 Billion viable cells per capsule when kept refrigerated and within Best Used Before Date.
- Suggested Use: For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.
|
| Storage |
- Keep refrigerated.
|
| Precautions |
- Keep out of reach of children.
- Contains: Dairy (casein, in trace amounts).
|
| FDA Disclaimer Statement |
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
| Seals/Symbols |
- GLUTEN FREE
|
| FDA Statement of Identity |
- ORAL PROBIOTIC SUPPLEMENT
|
| Formulation |
- No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no peanuts/tree nuts.
|
| General |
- 02514FEM60 PROD # 103030
|
Brand Information
See all products by this brand
| Distributed Exclusively by | |
|---|---|
| Name | Jarrow Formulas Superior Nutrition and Formulation |
| Street Address | P.O. Box 35994 |
| City | Los Angeles |
| State | CA |
| ZipCode | 90035-4317 |
| Web Address | www.Jarrow.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.